Endometrial effects of daily progesterone s.c. [subcutaneous] 25 and 50 mg aqueous formulation to female healthy volunteers
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Progesterone (Primary)
- Indications Amenorrhoea; Menopausal syndrome
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors IBSA
- 10 May 2007 New trial record.
- 20 Sep 2006 Biomarkers information updated